In cancer types with low frequencies of BRAF mutations such as leukemia, breast cancer, myeloproliferative neoplasms, head and neck cancer and esophagogastric cancer the author found high proportions of BRAF variants of unknown significance. This evidence concerns the gene BRAF and head and neck cancer.